Aug 13, 2020
Global Pancreatic and Biliary Stents Market Analysis (2015-2020) and Forecast (2020-2030) Model - Key Trends and Developments Resulting from the COVID-19 Pandemic
Jun 16, 2020
Pancreatic Cancer Action Network (PanCAN) Mobilizes Advocates From All 50 States - Virtually - To Call On Congress For Increased Federal Research Funding
Jun 11, 2020
Seven Bridges and the Pancreatic Cancer Action Network Partner to Develop High-Quality, Actionable Cancer Data Platform
Jun 02, 2020
RenovoRx Announces Orphan Drug Designation Granted for Treating Bile Duct Cancer
Jun 01, 2020
Gateway for Cancer Research Announces Recipient of Inaugural Discovery Grant
May 29, 2020
Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
May 27, 2020
BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine
May 21, 2020
CytRx Corporation Highlights Latest Positive Event From its Licensed Drug Aldoxorubicin
Apr 30, 2020
Focused Ultrasound Foundation and Pancreatic Cancer UK Partner to Fund Innovative Study
Apr 22, 2020
Pancreatic Cancer Cells Hijack Basic Cell Mechanism to Evade Immunotherapy
Mar 20, 2020
Immunovia Publishes the Annual Report for the Financial Year 2019
Mar 03, 2020
Spherix Executes Machine Learning Scientific Research Agreement
Mar 02, 2020
New Research Reveals Pancreatic Cancer Patients Who Receive Precision Medicine Live An Average Of One Year Longer Than Those Who Do Not
Mar 02, 2020
New Research Reveals Pancreatic Cancer Patients Who Receive Precision Medicine Live An Average Of One Year Longer Than Those Who Do Not
Mar 02, 2020
New Research Reveals Pancreatic Cancer Patients Who Receive Precision Medicine Live An Average Of One Year Longer Than Those Who Do Not
Feb 24, 2020
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China
Feb 13, 2020
Rush Earns National Center Of Excellence For Pancreatic Cancer Designation
Jan 27, 2020
Biotech Brief: Demand is Growing for Safer, More-Efficacious Drugs When Treating Pancreatic Cancer
Jan 27, 2020
Oncolytics Biotech® Announces Statistically Significant Data Identifying CEACAM6 as a Prospective Prognostic Biomarker for Pelareorep in the Treatment of Pancreatic Adenocarcinoma
Jan 24, 2020
BERG Presents Initial Clinical Data And Identification Of Response Biomarkers In A Phase 2 Pancreatic Cancer Trial Guided By Using The Interrogative Biology® Platform At ASCO-GI Meeting